Search

Your search keyword '"Fatty Acids, Volatile therapeutic use"' showing total 124 results

Search Constraints

Start Over You searched for: Descriptor "Fatty Acids, Volatile therapeutic use" Remove constraint Descriptor: "Fatty Acids, Volatile therapeutic use"
124 results on '"Fatty Acids, Volatile therapeutic use"'

Search Results

1. Advances in the mechanism of action of short-chain fatty acids in psoriasis.

2. The role of short-chain fatty acids in cancer prevention and cancer treatment.

3. Prophylactic Administration of Gut Microbiome Metabolites Abrogated Microglial Activation and Subsequent Neuroinflammation in an Experimental Model of Japanese Encephalitis.

4. Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis.

5. Gut microbial metabolites SCFAs and chronic kidney disease.

6. Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis.

7. Effects of short-chain fatty acids on blood glucose and lipid levels in mouse models of diabetes mellitus: A systematic review and network meta-analysis.

8. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.

9. Trans-vaccenic acid reprograms CD8 + T cells and anti-tumour immunity.

10. Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment.

11. Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study.

12. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases.

13. Regulation of Immune Homeostasis, Inflammation, and HIV Persistence by the Microbiome, Short-Chain Fatty Acids, and Bile Acids.

14. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids.

15. Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line.

16. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.

17. Short-Chain Fatty Acids in the Microbiota-Gut-Brain Axis: Role in Neurodegenerative Disorders and Viral Infections.

18. The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids.

19. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.

20. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.

21. Short Chain Fatty Acids (SCFAs) Are the Potential Immunomodulatory Metabolites in Controlling Staphylococcus aureus -Mediated Mastitis.

22. Nutrient sensing mechanism of short-chain fatty acids in mastitis control.

23. Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes.

24. Rutin-activated adipose tissue thermogenesis is correlated with increased intestinal short-chain fatty acid levels.

25. Influence of dietary supplementation of short-chain fatty acid sodium propionate in people living with HIV (PLHIV).

26. Regulatory role of short-chain fatty acids in inflammatory bowel disease.

27. Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials.

28. Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review.

29. SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine.

30. Host gut microbiome and potential therapeutics in Gulf War Illness: A short review.

31. Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.

32. Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids.

33. The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice.

34. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites.

35. Implication of Gut Microbiota in Cardiovascular Diseases.

36. Short-chain fatty acids as novel therapeutics for gestational diabetes.

37. Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF- κ B Signaling.

38. Promotion of wound healing by acetate in murine colonic epithelial cell via c-Jun N-terminal kinase activation.

39. Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: secondary analysis of a randomized controlled trial.

40. Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application.

41. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity.

42. Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment.

43. Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents.

44. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.

46. Effect of Oat and Tartary Buckwheat - Based Food on Cholesterol - Lowering and Gut Microbiota in Hypercholesterolemic Hamsters.

47. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes.

49. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.

50. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders.

Catalog

Books, media, physical & digital resources